CTIS, Inc. Announces Mrs. Bharti Shah, Chief Executive Officer and Welcomes Dr. Teresa Sligh, MD as its EVP & Chief Medical Officer and Mr. Bill Yarnoff As EVP Growth
Mrs. Shah has served CTIS in the capacity of Deputy CEO and Chief Empowerment Officer, she is an investor and co-owner at CTIS - Mrs. Shah brings leadership, customer service experience, and skills as she will lead to build CTIS's future together with the team. Dr. Teresa Sligh, MD appointed as Executive Vice President and Chief Medical Officer and Mr. Bill Yarnoff as Executive Vice President Growth.
ROCKVILLE, Md., Sept. 21, 2018 /PRNewswire-PRWeb/ -- - Bharti Shah, Chief Executive Officer
CTIS, Inc., Rockville, MD based Health Informatics company, today announced the promotion of Ms. Bharti Shah to Chief Executive Officer. She will have the primary responsibility of overseeing CTIS' business operations and development for growth opportunities and initiatives. She will continue providing leadership, coordination and day-to-day management for business operations and direct the back-office overseeing the Accounting department, employee well-being along with the HR team.
Mrs. Bharti Shah has more than 20 years of professional experience in the field of education, having served as vice president, director, and teacher at Montessori Children's House of Loudoun (MCHL). Although she has retired from teaching, she continues her philanthropic journey and believes it is important to give back to those in need globally and locally. Mrs. Shah has been committed to corporate citizenship through support of the healthcare needs of local and global communities, facilitating services in the areas of children's health and education. She is actively involved in sponsoring more than 50 schools in India, providing management, strategy planning, and informatics support to the Ekal Vidyalaya Foundation. With the Arogya Foundation, she has worked to develop a pilot project that involves the use of handheld devices for the advancement of rural health. Mrs. Shah has been involved with many global health projects including the International Spirit of Healing, the Art of Living Foundation, Health Related Information Dissemination Amongst Youth (HRIDAY) & Student Health Action Network (SHAN), International Network for Cancer Treatment and Research (INCTR), International Spirit of Life Foundation, and the Sri Sri University. Mrs. Shah has a bachelor's degree in commerce and economics from Mumbai University and has a Montessori teacher training and certification from the Institute for Advanced Montessori Studies' Barrie School.
- Dr. Teresa S. Sligh, MD - Executive Vice President and Chief Medical Officer
Dr. Teresa S. Sligh, MD, joins CTIS, Inc. as the Executive Vice President and Chief Medical Officer. She has served for 15 years as the founder and president of Translational Research Group, Inc., a special populations CRO and all-phase research center in Los Angeles conducting studies in internal medicine, endocrinology, infectious disease, chronic pain, gastrointestinal, respiratory, allergy and dermatology.
Dr. Sligh is returning to CTIS, Inc. where she previously served as the Chief Medical/Strategy Officer as an architect for CTRM, TrialBridge and other strategies.
Dr. Sligh is board eligible in Internal Medicine Research Path, having trained in Internal Medicine at Presbyterian Hospital of Dallas, Texas, and received her M.D. degree from Texas A&M College of Medicine. She completed graduate work in protease enzymology and received her Bachelor of Science degree in biochemistry from the University of New Mexico.
Initially as a biochemist, Dr. Sligh conducted basic research in metabolism, molecular and cellular biology. She subsequently worked as a medicinal biochemist in the analysis, characterization, manufacturing and quality of pharmaceuticals. Later she transitioned into clinical research serving as a drug development lead, CRA, IRB member, regulatory, quality and subject matter expert. In the past 20 years, Dr. Sligh has served as principal investigator on more than 450 clinical trials of biologics, pharmaceuticals, apheresis, cell therapies, devices, implantables, digital technologies (ingestible, wearable and handheld), real world, nutraceuticals and multidisciplinary therapies.
During her recent 10 year service as a board member for a publicly-held corporation, Dr. Sligh's vision leadership resulted in the re-focusing and transformation of a blood bank company into a niche supplier in the bioresearch space providing cGMP compliant cell collections for emerging markets in cell therapy. This internal startup was grown from $0 revenue in 2011 to $20.2M revenue in 2017 with no debt or dilution yielding a 2017 gross profit of 53%.
Dr. Sligh dedicates her efforts to evangelizing and improving clinical research as well as to providing free medical care to underserved populations.
- Mr. Bill Yarnoff, Executive Vice President of Growth
Mr. Bill Yarnoff, joins CTIS, Inc. as the Executive Vice President of Growth. Mr. Yarnoff, is a veteran of the technology marketplace, having held executive positions with numerous solution providers to the federal government. He has held leadership roles in direct sales, sales support, strategic partnership and alliance development, go-to-market strategy formulation, project and portfolio management, corporate branding, training, and related initiatives. Most recently, Bill led the formation and launch of the ACEL360 accelerator for Federal Government contractors. Prior to that, he launched the Meridian International Institute, the revenue-generating arm of the Meridian Global Leadership Institute. At Meridian, Bill oversaw the development of a multi-module professional development program. He was also responsible for creating pipelines of high-value prospects, negotiating strategic agreements with partners, developing a professional faculty, and formulating an e-learning strategy. Bill holds an undergraduate degree from the College of William and Mary; he also attended the Professional Studies Program at the University of Virginia.
SOURCE CTIS, Inc.
Share this article